miniming
Guest
Apr 26, 2021
7:54 PM
|
Headquarters: San Francisco
Founders: Abraham Heifets (CEO), Izhar Wallach
Funding: $174 million
Valuation: $423 million pgslot
Atomwise is powered by a drug discovery algorithm that uses a neural network to simulate how different small molecules may bind to a protein. The machine learning technique allows scientists to rapidly simulate the interactions of millions of molecules to determine which have potential in preclinical trials. Because of their convoluted structures and the complex ways they interact, thousands of proteins remain unlinked to any drug treatments. Atomwise’s 250 customers, which include research institutions like Columbia University and pharmaceutical companies like Bayer, are running nearly 800 projects across areas including cancer, clotting disorders and brain diseases. It’s already helped to discover promising drugs for multiple sclerosis and ebola which were successful in animal trials.
|
